A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes.
Kosugi H, Fujisaki T, Iwasaki H, Shinagawa A, Iida H, Jo T, Kubonishi S, Morita Y, Nakashima Y, Onodera K, Suzuki K, Suzuki T, Tamai Y, Usuki K, Yokota A, Yonaga H, Hayakawa J, Midorikawa S, Nishio M, Suda M, Matsue K.
Kosugi H, et al. Among authors: hayakawa j.
Int J Hematol. 2024 Nov 21. doi: 10.1007/s12185-024-03872-3. Online ahead of print.
Int J Hematol. 2024.
PMID: 39572468